← Back to Search

Immunomodulator

CequaTM (Cyclosporine 0.09%) ophthalmic solution for Dry Eye Syndrome

Phase 4
Waitlist Available
Research Sponsored by Sun Pharma Global FZE
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week12
Awards & highlights

Study Summary

This trial is testing an investigational drug for dry eye disease that is not controlled by current treatments. It will last 12 weeks and take place at multiple centers.

Eligible Conditions
  • Dry Eye Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week12
This trial's timeline: 3 weeks for screening, Varies for treatment, and week12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change From Baseline in Modified Dry Eye Scoring.
Mean Change in Baseline in Total Corneal Fluoroscein Staining Score
Secondary outcome measures
Changes From Baseline in Central Corneal Staining Score
Mean Change From Baseline in Frequency of Artificial Tear Product Use.
Mean Change in Baseline for Conjunctival Staining Assessment
+3 more

Side effects data

From 2022 Phase 4 trial • 135 Patients • NCT04357795
13%
Instillation Site Irritation
2%
Instillation Site Pain
100%
80%
60%
40%
20%
0%
Study treatment Arm
CequaTM (Cyclosporine 0.09%) Ophthalmic Solution

Trial Design

1Treatment groups
Experimental Treatment
Group I: CequaTM (Cyclosporine 0.09%) ophthalmic solutionExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CequaTM (Cyclosporine 0.09%) ophthalmic solution
2020
Completed Phase 4
~140

Find a Location

Who is running the clinical trial?

Sun Pharma Global FZELead Sponsor
33 Previous Clinical Trials
10,016 Total Patients Enrolled
Sun Pharmaceutical Industries LimitedLead Sponsor
64 Previous Clinical Trials
13,376 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Effect of Cequa™ in Subjects With Dry Eye Disease
2020. "Effect of Cequa™ in Subjects With Dry Eye Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04357795.
~28 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top